HeraMED, an innovative medical data and technology company, is leading the way in digital transformation for maternity care with its hybrid maternity care platform. The company's proprietary platform features hardware and software that aims to reshape the doctor-patient relationship using clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT. The platform incorporates cloud computing, artificial intelligence and big data to improve the prenatal and postpartum experience for mothers. HeraMED is poised to revolutionize maternity care with its groundbreaking technology.
HeraMED 's ticker is HMD
The company's shares trade on the ASX stock exchange
They are based in Netanya, Australia
There are 11-50 employees working at HeraMED
It is https://hera-med.com/
HeraMED is in the Healthcare sector